Verrica Pharmaceuticals Inc (VRCA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $54.97M
Last updated: Nov 17, 2026 at 4:32 PM ET
Verrica Pharmaceuticals Inc (VRCA) Stock Chart
Verrica Pharmaceuticals (VRCA) has a latest price of $3.14 on Nov 17, 2026, 68.0% below its 52-week high of $9.82. Its price fell 20.1% over the past 12 months. The month-end price fell 98.3% since Jun 2018, a compound annual decline of 38.7%.
Price Chart
From Jun 2018 to Oct 2026, its highest month-end close was $197.30 in Jun 2018 and its lowest $3.35 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart VRCA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VRCA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 37.1%, and over 6 months it fell 43.8%. The month-end price fell 90.9% over the 3 years through Oct 2026, a compound annual decline of 55.0%.
| Period | Change |
|---|---|
| 1 month | -8.7% |
| 3 months | -37.1% |
| 6 months | -43.8% |
| 12 months | -20.1% |
| 12 months, with dividends | -20.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -90.9% | -55.0% |
| 5 years | -97.3% | -51.6% |
| Since Jun 2018 | -98.3% | -38.7% |
Price by Year
Its best calendar year was 2023, when the price rose 166.2%, and its weakest was 2024, when it fell 90.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.35 | -59.7% |
| 2025 | $8.31 | +18.7% |
| 2024 | $7.00 | -90.4% |
| 2023 | $73.20 | +166.2% |
| 2022 | $27.50 | -70.0% |
| 2021 | $91.60 | -20.4% |
| 2020 | $115.10 | -27.6% |
| 2019 | $158.90 | +95.0% |
Trading Range
The price is 21.1% below its 50-day average of $3.98 and 41.5% below its 200-day average of $5.36.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.14 | |
| 52-week high | $9.82 | -68.0% |
| 52-week low | $3.08 | +1.9% |
| 50-day average | $3.98 | -21.1% |
| 200-day average | $5.36 | -41.5% |
Price Risk
Over 3 years, its largest fall from a peak was 96.8%.
| Measure | Value |
|---|---|
| 1-year beta | 2.23 |
| Largest fall, 1 year | -66.0% |
| Largest fall, 3 years | -96.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About VRCA
What is VRCA's 1-year price change?
Verrica Pharmaceuticals's price fell 20.1% over the past 12 months. With dividends included, the 12-month total return was -20.1%.
What is VRCA's 5-year price change?
Verrica Pharmaceuticals's month-end price fell 97.3% over the 5 years through Oct 2026, a compound annual decline of 51.6%. These figures leave out dividends.
What is VRCA's 52-week high and low?
Verrica Pharmaceuticals's 52-week high is $9.82 and its 52-week low is $3.08. Its latest price of $3.14 on Nov 17, 2026 is 68.0% below the high.
What is VRCA's beta?
Verrica Pharmaceuticals's 1-year beta against the S&P 500 is 2.23, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 66.0%.
Is the VRCA chart free?
Yes. Advanced Charting for VRCA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
VRCA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors